DM
VNDA icon

Deerfield Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Deerfield Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,299,046
Closed -$32.2M – 97
2017
Q1 		$32.2M Sell
2,299,046
-1,125,630
-33% -$16M 1.24% 29
2016
Q4 		$54.6M Sell
3,424,676
-10,900
-0.3% -$175K 2.25% 11
2016
Q3 		$57.2M Sell
3,435,576
-2,561,115
-43% -$34.5M 2.66% 10
2016
Q2 		$67.1M Hold
5,996,691
– – 2.64% 10
2016
Q1 		$50.1M Hold
5,996,691
– – 2.13% 14
2015
Q4 		$55.8M Buy
5,996,691
+1,212,534
+25% +$12.1M 2.26% 9
2015
Q3 		$54M Hold
4,784,157
– – 2.09% 8
2015
Q2 		$60.7M Buy
4,784,157
+650,000
+16% +$7.01M 2.02% 7
2015
Q1 		$38.4M Sell
4,134,157
-5,630
-0.1% -$63.6K 1.25% 22
2014
Q4 		$59.3M Buy
4,139,787
+1,971,112
+91% +$23.3M 2.13% 13
2014
Q3 		$22.5M Buy
2,168,675
+1,083,374
+100% +$14.2M 0.82% 43
2014
Q2 		$17.6M Buy
1,085,301
+583,592
+116% +$7.77M 0.71% 46
2014
Q1 		$8.15M Sell
501,709
-129,567
-21% -$1.84M 0.33% 72
2013
Q4 		$7.83M Sell
631,276
-188,724
-23% -$1.9M 0.41% 64
2013
Q3 		$8.98M Buy
+820,000
New +$8.76M 0.42% 68

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deerfield Management's VNDA Position: Q2 2017 in Review

Deerfield Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2017, closing a stake of 2,299,046 shares — an estimated $32.2M sold.

Deerfield Management first reported a position in VNDA in Q3 2013 and held it in 15 quarters. The position peaked at $67.1M in Q2 2016. 133 funds tracked by Wall St. Rank hold VNDA as of Q2 2017.

  • Deerfield Management reported no remaining Vanda Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Deerfield Management sold 2,299,046 Vanda Pharmaceuticals shares in Q2 2017, an estimated $32.2M.
  • Deerfield Management first reported a position in Vanda Pharmaceuticals in Q3 2013 and held it in 15 quarters.
  • Deerfield Management's Vanda Pharmaceuticals position peaked at $67.1M in Q2 2016.
  • 133 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2017.

Based on Deerfield Management's 13F filing for Q2 2017, filed 14 Aug 2017.